[1] |
Wong RS, Cheong SK. Leukaemic stem cells: drug resistance,metastasis and therapeutic implications[J].Malaysian J Pathol,2012, 34(2):77-88.
|
[2] |
Junia V.Melo,Timothy P.Hughes,et al.Chronic myeloid leukemia[J].Hematology,2003.
|
[3] |
Kusio-Kobialka M,Podszywalow-Bartnicka P,Peidis P,et al.The PERK-eIF2α phosphorylation arm is a pro-survival pathway of BCR-ABL signaling and confers resistance to imatinib treatment in chronic myeloid leukemia cells[J].Cell Cycle,2012,11(21):4 069-4 078.
|
[4] |
Gao Y, Lu N, Ling Y, et al. Oroxylin A inhibits angiogenesis through blocking vascular endothelial growth factor-induced KDR/Flk-1 phosphorylation[J].J Cancer Res Clin Oncol,2009,136(5):667-675.
|
[5] |
Li HN,Nie FF,Liu W,et al.Apoptosis induction of oroxylin A in human cervical cancer HeLa cell line in vitro and in vivo[J].Toxicology,2009,257(1/2):80-85.
|
[6] |
Zhu B,Zhao L,Zhu L,et al.Oroxylin A reverses CAM-DR of HepG2 cells by suppressing Integrinβ1 and its related pathway[J].Toxicol Appl Pharmacol,2012,259(3):387-394.
|
[7] |
Yang HY,Zhao L,Yang Z,et al.Oroxylin a reverses multi-drug resistance of human hepatoma BEL7402/5-FU cells via downregulation of P-glycoprotein expression by inhibiting NF-κB signaling pathway[J].Molecular Carcinogenesis,2012,51(2):185-195.
|
[8] |
Sun Y, Lu N, Ling Y, et al. Oroxylin A suppresses invasion through down-regulating the expression of matrix metalloproteinase-2/9 in MDA-MB-435 human breast cancer cells[J].Eur J Pharmacol,2009,603(1/2/3):22-28.
|
[9] |
Zhu L,Zhao L,Wang H,et al.Oroxylin A reverses P-glycoprotein-mediated multidrug resistance of MCF7/ADR cells by G2/M arrest[J].Toxicol Lett,2013,219(2):107-115.
|
[10] |
Yao J,Hu R,Sun J,et al.Oroxylin A prevents inflammation-related tumor through down-regulation of inflammatory gene expression by inhibiting NF-κB signaling[J].Mol Carcinog,2014,53(2):145-58.doi: 10.1002/mc.21958.
|
[11] |
Farias-de-Oliveira DA,Villa-Verde DM,Nunes Panzenhagen PH,et al.Caspase-8 and caspase-9 mediate thymocyte apoptosis in trypanosoma cruzi acutely infected mice[J].J Leukoc Biol,2013,93(2):227-234.
|
[12] |
Cheung CH,Huang CC,Tsai FY,et al.Survivin-biology and potential as a therapeutic target in oncology[J].Onco Targets Ther,2013,6:1 453-1 462.
|
[13] |
Gough DJ,Koetz L,Levy DE.The MEK-ERK pathway is necessary for serine phosphorylation of mitochondrial STAT3 and Ras-mediated transformation[J].PLoS ONE,2013,8(11):e83395.
|